ESA-SRB 2014* , ,
Presentations this author is a contributor to:
Metreleptin improves metabolic and hepatic endpoints in the treatment of non-HAART associated lipodystrophy syndromes: a meta-analysis into the effects of leptin replacement therapy. (#204)
3:15 PM
Alexander J Rodriguez
ESA Orals - New frontiers in endocrinology (clinical)